Search Results for 'pfizer'
Contract Service Directory Companies
Featured Companies
View All Buyers Guide Companies »
-
Breaking News | Industry News
Pfizer, BioNTech Enter Vax Pact with COVAX
Initial agreement provides up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine to COVAX in 2021, with first deliveries expected in 1Q21.Kristin Brooks 01.22.21
-
Breaking News | Promotions & Moves
Pfizer Appoints President of AfME Region
Patrick van der Loo’s experience spans more than 20 years at Pfizer in leadership roles across multiple geographies.Contract Pharma Staff 01.12.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Pfizer, BioNTech Covid-19 Vax Authorized in the U.S.
First doses to be delivered across the nation today in healthcare facilities.Contract Pharma Staff 12.14.20
-
Breaking News | Industry News | Trials & Filings
Health Canada Authorizes Pfizer, BioNTech COVID-19 Vax
Pfizer Canada and BioNTech will supply the Government of Canada a minimum of 20 million doses and up to 76 million doses of the vaccine through 2021.Contract Pharma Staff 12.10.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Trials & Filings
Pfizer, BioNTech Win First Authorization for COVID-19 Vax
MHRA authorizes supply of BNT162b2 vaccine for emergency supply; companies are ready to deliver the first doses to the U.K. immediately.Contract Pharma Staff 12.02.20
-
Pfizer, BioNTech Submit CMA for Covid-19 Vax to EMA
Approval could potentially enable the use of BNT162b2 in Europe before the end of 2020.Contract Pharma Staff 12.01.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Pfizer and BioNTech to Submit EUA for COVID-19 Vaccine
Expect to produce globally up to 50 million doses in 2020, up to 1.3 billion doses by the end of 2021; ready to distribute within hours after authorization.Contract Pharma Staff 11.20.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture
Delpharm to Manufacture Pfizer/BioNTech mRNA Vax in France
Will begin manufacturing BNT 162b2 in April 2021 and will produce tens of millions of doses.Contract Pharma Staff 11.19.20
-
Trials & Filings
Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study
Meets all primary efficacy endpoints, demonstrates BNT162b2 to be 95% effective against COVID-19.Contract Pharma Staff 11.18.20
-
Pfizer’s COVID-19 Vax Breakthrough
mRNA-based vaccine candidate found to have an efficacy rate above 90% in preventing COVID-19.Tim Wright, Editor 11.17.20
-
Breaking News | Industry News
Pfizer, BioNTech to Supply 200M Doses of BNT162b2 to EU
Deliveries are anticipated to start by the end of 2020, subject to clinical success and regulatory authorization.Contract Pharma Staff 11.11.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Pfizer, BioNTech COVID-19 Vax Candidate Successful in Phase III Interim Analysis
mRNA-based vaccine candidate BNT162b2 found to be more than 90% effective in preventing COVID-19.Contract Pharma Staff 11.09.20
-
Financial Reports
Financial Report: Pfizer
Revenues down 4% in the quarter to $12.1 billion.Contract Pharma Staff 11.04.20
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
CStone, Pfizer Enter Antibody Alliance
To support CStone’s development of sugemalimab, a potential best-in-class PD-L1 antibody being developed for high-incidence cancer indications in China.Contract Pharma Staff 09.30.20
-
November 2020: Auction of Packaging Equipment of Vaccines and Injectable Products from Pfizer Havant
United Kingdom
-
Breaking News | Industry News | Promotions & Moves
Pfizer CentreOne Appoints General Manager
Andrew Moore joins the company from CogxVision.Contract Pharma Staff 09.14.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Pfizer, BioNTech Inch Closer to COVID-19 Vax Deal with EU
Could supply the EU with 200 million doses of mRNA-based vaccine candidate against SARS-CoV-2.Contract Pharma Staff 09.10.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Florence, Pfizer Partner to Support COVID-19 Vax
Global Phase 2/3 study to leverage site and sponsor connectivity platform across 27 countries.Contract Pharma Staff 09.09.20
-
Breaking News | Clinical Trials | Collaborations & Alliances | Toxicology
NKMax America Partners with Merck KGaA and Pfizer
Will evaluate the safety and tolerability of SNK01 in combination with avelumab (BAVENCIO).Contract Pharma Staff 09.09.20
-
Breaking News | Clinical Trials | Drug Development | Industry News
Parexel, Pfizer Extend Long-Term Partnership
Parexel will provide clinical development services via full-service, hybrid and functional service provider (FSP) models across all therapeutic areas.Contract Pharma 08.27.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Pfizer, Gilead Partner to Manufacture Remdesivir for Treatment of COVID-19
Pfizer will provide contract manufacturing services at its McPherson, KS facility.Contract Pharma Staff 08.13.20
-
Financial Reports
Financial Report: Pfizer
Biopharma revenues were $9.8 billion, up 6% operationally, primarily driven by Vyndaqel.Contract Pharma Staff 08.12.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Pfizer, BioNTech Reach Deal with Japanese Government
Supply of 120 million vaccine doses to be provided in the first half of 2021, subject to regulatory approval.Contract Pharma Staff 08.03.20
-
Breaking News | Clinical Trials | CRO News | Drug Development | Laboratory Testing
PPD, Pfizer Ink New Service Pact
PPD to provide drug development services to advance Pfizer’s portfolio under new three-year agreement.Contract Pharma Staff 08.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
U.S. Inks $2B COVID-19 Vax Deal with Pfizer, BioNTech
U.S. government placed an initial order of 100 million doses and can acquire up to 500 million additional doses.Contract Pharma Staff 07.23.20
-
-
Breaking News | Clinical Trials | CRO News | Drug Development
Syneos Health, Pfizer Ink New Service Agreement
Three-year agreement to provide global product development services to support Pfizer's portfolio.Contract Pharma Staff 07.13.20
-
EMD Serono, Pfizer Win FDA Approval for sBLA for BAVENCIO
For the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma.Contract Pharma Staff 07.01.20
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
BioInvent, Pfizer Extend Immunotherapy Research Term
Allows the companies to further identify and characterize new targets and antibodies leveraging BioInvent's F.I.R.S.T drug discovery platform.Contract Pharma Staff 07.01.20
-
Collaborations & Alliances | Drug Development
Valneva Earns $130M Pfizer Milestone in Lyme Vax Pact
Working to develop and commercialize Valneva’s Lyme disease vaccine candidate VLA15, which is currently in Phase II clinical studies.Contract Pharma Staff 06.09.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | R&D
Pfizer Unveils $500M Biotech Fund
New program to support continued biotechnology innovation across a portfolio of clinical-stage biotechnology companiesContract Pharma Staff 06.02.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Valneva Collaborates with Pfizer On Lyme Disease Vaccine
VLA15 is being evaluated for adult and pediatric indications in North America and EuropeContract Pharma Staff 04.30.20
-
Financial Reports
Financial Report: Pfizer
Biopharma revenues up 11% in the quarter to $10.0 billion; generic competition impacts Upjohn revenues.Contract Pharma Staff 04.29.20
-
Breaking News | Facilities | Industry News
ISPE Award Honors New Pfizer Facility
Engineered and designed by CRB, Andover Clinical Manufacturing Facility focuses on integration and flexibility to speed patient therapiesContract Pharma Staff 04.13.20
-
Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
ICON Signs New Service Agreement with Pfizer
ICON provides services for Pfizer’s clinical trials worldwideContract Pharma Staff 04.13.20
-
Breaking News | Industry News
Pfizer Advances Battle Against COVID-19 on Multiple Fronts
Anti-viral compounds show activity against SARS-CoV-2 in preclinical screeningContract Pharma Staff 04.13.20
-
The Supply Chain House of Cards
The COVID-19 pandemic exposes pressures on extended global supply chainsEmil W. Ciurczak, DoraMaxx Consulting 04.01.20
-
Drug Delivery
CEO Spotlight: Will Downie
Vectura’s chief executive talks trends in the inhaled-drug market, and the company’s transition into a CDMOTim Wright, Editor, Contract Pharma 04.01.20
-
cGMP Manufacture
Elevating Process Engineering to Improve Predictability, Reliability & Productivity
It is past time for drug makers to shift from a document- and compliance-centered paradigm to one focused on science and engineeringCathal Strain, President, Neo PLM 03.18.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Pfizer, BioNTech to Co-Develop Potential COVID-19 Vaccine
Will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection03.18.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioNTech Reports Progress on COVID-19 Vaccine Program
Partnered with Fosun in China and Pfizer elsewhere; anticipates start of clinical testing for vaccine in late April 202003.16.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Drug Development
Newsmakers: Thermo Fisher Scientific
Leon Wyszkowski discusses the company’s recent investments, the challenges biopharma companies face, and future needs in the outsourcing spaceOnline Exclusives03.16.20
-
Breaking News | Promotions & Moves
-
Chemistry
Greener by Design
How new approaches to green chemistry are driving sustainable processes.Kenneth Ball, Commercial Operations Lead, Pfizer CentreOne 03.04.20
-
Drug Development
Embedding Your Drug Strategy Within a Solid Foundation for Success
A review of the market dynamics and drug development trends driving strategic outsourcing decisions.
-
Breaking News | Promotions & Moves
Mylan, Pfizer Appoint Viatris CFO
Upjohn's Sanjeev Narula brings global experience and leadership02.27.20
-
Drug Development
Major Drug Approvals of 2019
Abbvie, Novartis, Pfizer and J&J score big wins with blockbuster potentialOnline Exclusives Kristin Brooks, Contract Pharma 02.24.20
-
Breaking News | Promotions & Moves
AskBio Appoints Product Development SVP
Anna Tretiakova will lead the company’s research and translational collaborations to deliver clinical candidate vectors02.19.20
-
cGMP Manufacture | Information Technology | Scale-up/Technology Transfer
The Future of Pharmaceutical Manufacturing
Neo PLM’s Cathal Strain discusses the need for a digital revolution to drive manufacturing innovationOnline Exclusives Kristin Brooks, Contract Pharma 02.12.20
-
Breaking News | Promotions & Moves
Eisai Expands Leadership Team
Adds two key appointments in the areas of Corporate Affairs and Market Access02.03.20
